Merck S.A. de C.V.

Non-Quoted Public Company
Calle 5, No. 7, Fracc. Industrial Alce Blanco, Naucalpan de Juarez,  53370, Mexico
()52 55 2122 1600, 52 55 2122 1703 fax, http://www.merck.com.mx

Primary SIC: Pharmaceutical Preparations, Primary NAICS: Pharmaceutical Preparation Manufacturing
Description: Manufacturing: Manufacture of pharmaceuticals and pigments

View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!

Merck S.A. de C.V., News and Information

Pyro Pharmaceuticals, Inc. Announces the Appointment of Robert C. Moellering, Jr., M.D. as Chairman of the Scientific Advisory Board.
Business Wire; 11/10/2009; 1221 words; ...shares of the Company's common stock, with...approval of Pyro's shareholders and procurement...financing. Robert C. Moellering, Jr...companies including Merck, Glaxo, Vertex...clinical utility. Pyro's techniques allow the...Company Filings," and (v) risk factors to be...

Other News To Note.
BIOWORLD Today; 11/3/2009; 2896 words; ...of Wilmington, N.C., cut its headcount...the sale of the M.V.I. and Aquasol product...said. AaiPharma's stock (NASDAQ:AAII...million milestone from Merck & Co. Inc., of Whitehouse...Agreement with the U.S. Army Medical Research...for testing of AVI's Neugene antisense therapeutics...

www.Xtremepicks.Com: Xtremepicks Alerts November 2, 2009 : PFWD, HGSI, AVGO and GTCB.
M2 Presswire; 11/2/2009; 1884 words; ...safety. Phase Forward's products and services...Eli Lilly, the U.S. Food and Drug Administration...Research Institute, Merck Serono, Novartis...treat lupus, hepatitis C, inhalation anthrax...additions to Avago's SPF+ transceiver series...competencies in III-V compound and silicon...

MXWL, CRXL, MRH, NXG, WST, PACR Expected To Be Lower After Earnings Releases on Tuesday.
M2 Presswire; 10/30/2009; 3309 words; ...Releases on Tuesday(C)1994-2009 M2 COMMUNICATIONS...After CRXL Crucell N.V. (ADR) 12 quarters...vital to the market's perception of the vitality...California. Crucell N.V. (NASDAQ: CRXL...worldwide. Crucell's core portfolio includes...Wyeth, GSK, CSL and Merck & Co. Crucell is ...

Weitz & Luxenberg News: Court Affirms $4.5 Million Award in Vioxx Trial and Dismisses Appeal by Merck & Co. on Preemption after Wyeth ruling.
Heart Disease Weekly; 10/18/2009; 1243 words; ...Luxenberg P.C. (www...appeal by Merck & Co...case McDarby v. Merck. The case...of Merck's prescription...Luxenberg P.C.). "Although...Court in Wyeth v. Levine...granted to Merck, thus fully...McDarby's family will...Luxenberg P.C. Weitz...

Why Purchase This Company Profile?

  • Sales prospecting
  • Competitive analysis
  • Vendor & supplier evaluation
  • Customer evaluation and analysis
  • Strategic planning

Need More Information?

Start a new search

Tell Us What You Think

Take our short survey to tell us what would make Goliath more valuable to you.

Add Your Company Information to Goliath
If your company does not appear in Goliath, click here to add it.

Update Your Company Information
If your company information has changed or is not correct,
click here to let us know.